News Headlines Article

Senate OKs measure to reauthorize user-fee programs
Modern Healthcare

The Senate easily passed a reauthorization of the Food and Drug Administration’s drug and device user-fee programs and authorized new generic and biosimilar user-fee programs.

The 96-1 vote to pass the measure followed a series of close votes that crossed partisan lines in which the chamber rejected a series on amendments, including one to allow the importation of pharmaceuticals from Canada.